{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:53:40Z","timestamp":1772229220145,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.imbio.2023.152711","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T22:05:21Z","timestamp":1690322721000},"page":"152711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical study of autonomic dysfunction in patients with autoimmune encephalitis"],"prefix":"10.1016","volume":"228","author":[{"given":"Jiao","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 6","key":"10.1016\/j.imbio.2023.152711_b0005","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/brain\/120.6.923","article-title":"Limbic encephalitis and small cell lung cancer. Clinical and immunological features","volume":"120","author":"Alamowitch","year":"1997","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.imbio.2023.152711_b0010","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","article-title":"Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types","volume":"260","author":"Baumgartner","year":"2013","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.imbio.2023.152711_b0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00415-015-8002-2","article-title":"Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings","volume":"263","author":"Baysal-Kirac","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.imbio.2023.152711_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: A systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.imbio.2023.152711_b0025","doi-asserted-by":"crossref","unstructured":"Budhram A., et al. Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis. Clin Chem. 2020. 66 (12). 1496-1509.","DOI":"10.1093\/clinchem\/hvaa254"},{"key":"10.1016\/j.imbio.2023.152711_b0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.autneu.2015.08.002","article-title":"Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis","volume":"193","author":"Byun","year":"2015","journal-title":"Auton Neurosci"},{"issue":"12","key":"10.1016\/j.imbio.2023.152711_b0035","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrn1556","article-title":"Receptor trafficking and synaptic plasticity","volume":"5","author":"Collingridge","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.imbio.2023.152711_b0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.imbio.2023.152711_b0045","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.imbio.2023.152711_b0050","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/neuonc\/nou030","article-title":"Autoimmune encephalitis update","volume":"16","author":"Dalmau","year":"2014","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.imbio.2023.152711_b0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.imbio.2023.152711_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.imbio.2023.152711_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-62225-2","article-title":"Assessing Autonomic Function from Electrodermal Activity and Heart Rate Variability During Cold-Pressor Test and Emotional Challenge","volume":"10","author":"Ghiasi","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.imbio.2023.152711_b0070","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 7","key":"10.1016\/j.imbio.2023.152711_b0075","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.imbio.2023.152711_b0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10286-012-0184-4","article-title":"Anti-NMDA receptor encephalitis with paroxysmal sympathetic hyperactivity: an under-recognized association?","volume":"23","author":"Hinson","year":"2013","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.imbio.2023.152711_b0085","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3389\/fneur.2018.01136","article-title":"Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis","volume":"9","author":"Huang","year":"2018","journal-title":"Front Neurol"},{"issue":"16","key":"10.1016\/j.imbio.2023.152711_b0090","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.imbio.2023.152711_b0095","doi-asserted-by":"crossref","unstructured":"Irani, S.R., et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010. 133 (9). 2734-48.","DOI":"10.1093\/brain\/awq213"},{"issue":"4","key":"10.1016\/j.imbio.2023.152711_b0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.imbio.2023.152711_b0105","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.imbio.2023.152711_b0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigens\u2013pathogenesis, associated disorders and antibody testing","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.imbio.2023.152711_b0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.imbio.2023.152711_b0120","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1212\/NXI.0000000000000386","article-title":"Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity","volume":"4","author":"Lang","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.imbio.2023.152711_b0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s13311-020-00921-7","article-title":"Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis","volume":"18","author":"Lee","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.imbio.2023.152711_b0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.imbio.2023.152711_b0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10286-020-00691-4","article-title":"Cardiovascular autonomic function testing in multiple system atrophy and Parkinson's disease: an expert-based blinded evaluation","volume":"30","author":"Leys","year":"2020","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.imbio.2023.152711_b0140","first-page":"1","article-title":"A systematic review of Gamma-aminobutyric Acid Receptor Type B autoimmunity","volume":"53","author":"McKay","year":"2019","journal-title":"Neurol Neurochir Pol"},{"issue":"2","key":"10.1016\/j.imbio.2023.152711_b0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(12)70319-8","article-title":"The importance of early and sustained treatment of a common autoimmune encephalitis","volume":"12","author":"McKeon","year":"2013","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.imbio.2023.152711_b0150","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","article-title":"Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis","volume":"78","author":"Nosadini","year":"2021","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.imbio.2023.152711_b0155","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","article-title":"Immune therapy in autoimmune encephalitis: a systematic review","volume":"15","author":"Nosadini","year":"2015","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"10.1016\/j.imbio.2023.152711_b0160","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tins.2007.03.012","article-title":"NMDA and AMPA receptors: old channels, new tricks","volume":"30","author":"Rao","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.imbio.2023.152711_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ensci.2022.100395","article-title":"Thymoma-associated anti-LGI1 encephalitis and myasthenia gravis: A unique combination with autoantibodies","volume":"27","author":"Satake","year":"2022","journal-title":"eNeurologicalSci"},{"issue":"6","key":"10.1016\/j.imbio.2023.152711_b0170","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","article-title":"Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing","volume":"78","author":"Sechi","year":"2021","journal-title":"JAMA Neurol"},{"issue":"1\u20132","key":"10.1016\/j.imbio.2023.152711_b0175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000353982","article-title":"Immunopathological significance of ovarian teratoma in patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"71","author":"Tabata","year":"2014","journal-title":"Eur Neurol"},{"issue":"2","key":"10.1016\/j.imbio.2023.152711_b0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.imbio.2023.152711_b0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.imbio.2023.152711_b0190","doi-asserted-by":"crossref","unstructured":"Valencia-Sanchez, C., et al., Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis. Brain Commun. 2021. 3(2). fcaa233.","DOI":"10.1093\/braincomms\/fcaa233"},{"issue":"5","key":"10.1016\/j.imbio.2023.152711_b0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neucli.2020.09.004","article-title":"Computerized dynamic pupillometry as a screening tool for evaluation of autonomic activity","volume":"50","author":"Venkata Sivakumar","year":"2020","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.imbio.2023.152711_b0200","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fneur.2020.00280","article-title":"Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis","volume":"11","author":"Wang","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.imbio.2023.152711_b0205","doi-asserted-by":"crossref","first-page":"7506590","DOI":"10.1155\/2020\/7506590","article-title":"Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.imbio.2023.152711_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.609750","article-title":"Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis","volume":"12","author":"Yan","year":"2021","journal-title":"Front Neurol"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523045138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523045138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:52:21Z","timestamp":1759251141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298523045138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0171298523045138"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152711","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical study of autonomic dysfunction in patients with autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152711"}}